Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Journal of Biomedical Research & Environmental Sciences
|
October 22, 2025
Inflammation Markers and HCC Aggressiveness
Brian Irving Carr, Rossella Donghia
Oncology
|
April 8, 2025
Factors Relating to Tumor Size and Survival in Patients with Hepatocellular Carcinoma: Significance of Platelet-Lymphocyte Ratio, Portal Vein Thrombosis, and Albumin
Rossella Donghia, Brian Irving Carr, Sezai Yilmaz
Journal of Clinical Gastroenterology
|
September 17, 2011
Prospective randomized trial of hepatic artery chemotherapy with cisplatin and doxorubicin, with or without lipiodol in the treatment of advanced stage hepatocellular carcinoma
Brian Irving Carr, Klaus Bron, Dennis P Swanson
Journal of Inonu Liver Transplantation Institute
|
September 3, 2025
A Network Phenotyping Strategy approach in a Turkish HCC Dataset and Comparison of Patients Selected for Transplant and those who were not
Petr Pancoska, Brian Irving Carr, Volkan Ince, et al.
Cancers
|
March 14, 2020
Inflammatory Mechanisms of HCC Development
Maria Grazia Refolo, Caterina Messa, Vito Guerra, et al.
Hepatology Forum
|
March 15, 2024
HBV viral load and tumor and non-tumor factors in patients with HBV-associated HCC
Engin Ataman, Murat Harputluoglu, Brian Irving Carr, et al.
Cancer Chemotherapy and Pharmacology
|
April 25, 2015
Modulation of Regorafenib effects on HCC cell lines by epidermal growth factor
Rosalba D'Alessandro, Maria Grazia Refolo, Catia Lippolis, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
September 3, 2015
Resistance to multikinase inhibitor actions mediated by insulin like growth factor-1
Catia Lippolis, Maria Grazia Refolo, Rosalba D'Alessandro, et al.
Cancers
|
June 12, 2019
Ramucirumab and GSK1838705A Enhance the Inhibitory Effects of Low Concentration Sorafenib and Regorafenib Combination on HCC Cell Growth and Motility
Rosalba D'Alessandro, Maria Grazia Refolo, Palma Aurelia Iacovazzi, et al.
Oncotarget
|
December 22, 2017
IGF-1R tyrosine kinase inhibitors and Vitamin K1 enhance the antitumor effects of Regorafenib in HCC cell lines
Maria Grazia Refolo, Rosalba D'Alessandro, Catia Lippolis, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Journal of Biomedical Research & Environmental Sciences
|
October 22, 2025
Inflammation Markers and HCC Aggressiveness
Brian Irving Carr, Rossella Donghia
Oncology
|
April 8, 2025
Factors Relating to Tumor Size and Survival in Patients with Hepatocellular Carcinoma: Significance of Platelet-Lymphocyte Ratio, Portal Vein Thrombosis, and Albumin
Rossella Donghia, Brian Irving Carr, Sezai Yilmaz
Journal of Clinical Gastroenterology
|
September 17, 2011
Prospective randomized trial of hepatic artery chemotherapy with cisplatin and doxorubicin, with or without lipiodol in the treatment of advanced stage hepatocellular carcinoma
Brian Irving Carr, Klaus Bron, Dennis P Swanson
Journal of Inonu Liver Transplantation Institute
|
September 3, 2025
A Network Phenotyping Strategy approach in a Turkish HCC Dataset and Comparison of Patients Selected for Transplant and those who were not
Petr Pancoska, Brian Irving Carr, Volkan Ince, et al.
Cancers
|
March 14, 2020
Inflammatory Mechanisms of HCC Development
Maria Grazia Refolo, Caterina Messa, Vito Guerra, et al.
Hepatology Forum
|
March 15, 2024
HBV viral load and tumor and non-tumor factors in patients with HBV-associated HCC
Engin Ataman, Murat Harputluoglu, Brian Irving Carr, et al.
Cancer Chemotherapy and Pharmacology
|
April 25, 2015
Modulation of Regorafenib effects on HCC cell lines by epidermal growth factor
Rosalba D'Alessandro, Maria Grazia Refolo, Catia Lippolis, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
September 3, 2015
Resistance to multikinase inhibitor actions mediated by insulin like growth factor-1
Catia Lippolis, Maria Grazia Refolo, Rosalba D'Alessandro, et al.
Cancers
|
June 12, 2019
Ramucirumab and GSK1838705A Enhance the Inhibitory Effects of Low Concentration Sorafenib and Regorafenib Combination on HCC Cell Growth and Motility
Rosalba D'Alessandro, Maria Grazia Refolo, Palma Aurelia Iacovazzi, et al.
Oncotarget
|
December 22, 2017
IGF-1R tyrosine kinase inhibitors and Vitamin K1 enhance the antitumor effects of Regorafenib in HCC cell lines
Maria Grazia Refolo, Rosalba D'Alessandro, Catia Lippolis, et al.
Page
of 2